283 related articles for article (PubMed ID: 15161983)
1. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
2. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort.
Lopez R; Davidson JE; Beeby MD; Egger PJ; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):491-8. PubMed ID: 22109798
[TBL] [Abstract][Full Text] [Related]
3. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
4. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
5. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study.
Stoll T; Sutcliffe N; Klaghofer R; Isenberg DA
Ann Rheum Dis; 2000 Oct; 59(10):832-5. PubMed ID: 11005787
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
7. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
8. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
Cardoso CR; Signorelli FV; Papi JA; Salles GF
Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
[TBL] [Abstract][Full Text] [Related]
9. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
10. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
11. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
12. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
13. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual.
Bertoli AM; Vilá LM; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcón GS;
Rheumatology (Oxford); 2007 Sep; 46(9):1471-6. PubMed ID: 17650522
[TBL] [Abstract][Full Text] [Related]
17. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
Chaiamnuay S; Bertoli AM; Fernández M; Apte M; Vilá LM; Reveille JD; Alarcón GS;
J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
19. Definition and treatment of lupus flares measured by the BILAG index.
Gordon C; Sutcliffe N; Skan J; Stoll T; Isenberg DA
Rheumatology (Oxford); 2003 Nov; 42(11):1372-9. PubMed ID: 12810926
[TBL] [Abstract][Full Text] [Related]
20. A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus.
Allen E; Farewell VT; Isenberg DA; Gordon C
Rheumatology (Oxford); 2006 Mar; 45(3):308-13. PubMed ID: 16249244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
